Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 192,330 shares at $10.03 ($1.9M) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Scheduled sale ($1.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.03 | 8,400 | $84K | 4.4% |
| 2 | $10.03 | 43,882 | $440K | 22.8% |
| 3 | $10.03 | 43,882 | $440K | 22.8% |
| 4 | $10.02 | 8,400 | $84K | 4.4% |
| 5 | $10.02 | 43,883 | $440K | 22.8% |
| 6 | $10.02 | 43,883 |
| $440K |
| 22.8% |
| Total | $10.02 avg | 192,330 | $1.9M | 100% |
| Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |
| ITOS | SELL | 2022-01-26 | $1.0M | — | Filing → |